Matt Hancock has told MPs that the Tier 3 restrictions imposed before thesecond national lockdown in England were not strong enough. The Prime Ministerhas since unveiled beefed-up tiered restrictions which are due to come intoplace next month. Mr Hancock told a joint session of the Health and SocialCare Committee and Science and Technology Committee: “The trigger thatpersuaded me that we needed to go into national lockdown, having beenessentially the architect of the tiered system and a big supporter of it, wasthat we saw case rates going up suddenly and quite sharply in almost everypart of England."
Credit: PA - Press Association STUDIO Duration: 01:04Published
Health Secretary Matt Hancock says he hopes the rollout of a new Covid vaccine can begin next month, with the bulk of the deployment continuing in the new year.
The vaccine, developed by the University of Oxford and AstraZeneca, could prevent 70.4% of people from getting the virus and up to 90% if a lower dose is used. Report by Alibhaiz. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Interview with Jack Sommers, a volunteer on the AstraZeneca and OxfordUniversity Covid-19 trial, said it was hard to believe how quickly scientistshad developed the vaccine. Mr Sommers experienced mild side effects – aslightly raised temperature and a pain in his shoulder – while Ms Hurst feltnone at all. Volunteers receive no information about how the trial is going sohave been following the progress in the media along with everybody else. AndMr Sommers said that, while he had been very pleased to read about positiveresults from other vaccines such as that developed by Pfizer, there was aspecial feeling about this one.
Credit: PA - Press Association STUDIO Duration: 01:15Published
Hopes for ending the pandemic rest on vaccines that could get approval in a matter of weeks, but public health experts caution that there are still many difficult hurdles to overcome before a vaccine..